SYNDAX PHARMACEUTICALS, INC.

Company

Syndax Pharmaceuticals Inc

Filed

April 8, 2019

Accession Number

0000902664-19-001816

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →